Cancer, Advanced Completed Phase 1 Trials for Irinotecan (DB00762)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00708773Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid TumorsTreatment
NCT00980239HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to LiverTreatment
NCT01463982Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid MalignanciesTreatment